Notice ID: 1a90358cb2da4bc8a6f6e49410962b7bSolicitation
Manufacturing and Nonclinical Studies Support for the Development of Therapeutic Biotechnology Products (Biologics) for Neurological-related Disorders
Archived on March 29, 2022. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 5:00 PM UTC−04:00
- Posted
- March 1, 2022
- Notice type
- Solicitation
- NAICS
- 541714: Research and Development in Biotechnology (except Nanobiotechnology)
- Agency
- Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH
Notice details
- Office
- NATIONAL INSTITUTES OF HEALTH NIDA
- Last updated
- Sep 9, 2025
Identifiers
- Solicitation number
- 75N95022R00013
- Notice ID
- 1a90358cb2da4bc8a6f6e49410962b7b
Description
Amendment 2: Q&A part 2 and revised Section M posted Amendment 1: Q&A part 1 posted and proposal due date extended The National Institute of Neurological Disorders and Stroke (NINDS) has a need for current Good Manufacturing Practices (cGMP) manufacturing and Good Laboratory Practice (GLP) nonclinical (preclinical) support services to support translational development of therapeutic biotechnology products (Biologics) for NIH drug discovery and development programs. To that end, several NIH programs are being launched or expanded to provide support for investigators developing medical interventions for neurological disorders, including the NIH Blueprint Neurotherapeutics (BPN) network, the NINDS Ultra-Rare Gene Therapy (URGenT) program, and the Helping to End Addiction Long-term Pain Therapeutics Development Program (HEAL-PTDP). Contractors must provide support for both Biologics cGMP manufacturing and GLP nonclinical services, including execution of the studies and completion of study reports and documentation that will enable regulatory filing and evaluation of biological therapeutics in clinical trials for NIH drug development programs. These services may be provided through a combination of internally executed studies and subcontracted work. All work in support of NIH biologics programs will be awarded through issuance of task orders against indefinite delivery, indefinite quantity (IDIQ) contracts. Please see the RFP and attachments for more information and review all instructions carefully. All proposals must be submitted through NIH's electronic Contract Proposal Submission (eCPS) and contain all required information/documentation. Additonally, all offerors must have an active SAM registration at the time of proposal submission to be considered for award.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
75N95022R00013- Pre-Solicitation
- Solicitation
Award typically follows within 30–90 days after the response deadline. (estimate)
- 9×Pre-SolicitationDec 2, 2021
Manufacturing and Nonclinical Studies Support for the Development of Therapeutic Biotechnology Products (Biologics) for Neurological-related Disorders
- 5×SolicitationCurrentJan 25, 2022
Manufacturing and Nonclinical Studies Support for the Development of Therapeutic Biotechnology Products (Biologics) for Neurological-related Disorders
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
75N95022R00013
Archive Date
Mar 29, 2022
Office Address
Bethesda, MD, 20892